Celularity’s Published In ‘Journal For ImmunoTherapy Of Cancer’ Reveals Placental Circulating T Cells For CAR-T Therapy
Celularity Inc. (NASDAQ:CELU) ("Celularity"), a regenerative and cellular medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products, announced today that the Journal